the "vast number of patient-oriented pharmacists" to whom you refer. Patient-oriented is undefined and imprecise, and should refer to virtually all pharmacists.
Our verbal sparring may cloud an important constructive moment. It has been fashionable the past few years to pontificate that pharmacy is a clinical profession. It certainly should be, but what is the definition of clinical and what are the standards? Your statement that the APhA's clinical section has 1800 members belies pharmacy as a clinical profession. Throw in the ACCP membership of less than 2000 and members of the ASHP specialty practice groups, and less than 10 percent of American pharmacists even belong to a clinical group. When overlapping membership is considered, the numbers are more bleak. With pharmacy education moving toward the all-Pharm.D, degree, now is the time for all pharmacy organizations to seriously study how to improve the profession's performance relative to its possibilities. Clinicians and scientists are increasingly called upon to present clinical information in an organized and succinct way. Presentation of Clinical Data provides comprehensive guidance in this area by illustrating how to report data well (i.e., to communicate information and not discuss statistical evaluations of data). It is a rich source of ideas that will be useful to all who plan to present scientific or clinical data for oral or written presentation. This book will be useful during both the design phase of a clinical study and at the study's conclusion when data is to be organized for presentation. It gives new insight into what types of measurements can be used, how to approach single-or multiple-patient data, and how to approach multi-or single-center data.
Chapter One provides a detailed discussion and guidelines for three basic formats of data presentation: tables, graphs, and figures. Explicit rules are presented to illustrate when each format is best used. Chapter Two discusses choosing a format and the basic composition used for preparing slides and transparencies.
After this introduction a topic approach to individual types of data is taken. Individual chapters are devoted to the presentation of study designs, patient demographics, vital signs, laboratory data, adverse reactions, efficacy, pharmacokinetics, quality of life, compliance, concomitant therapy, cost effectiveness, and meta-analysis. Literally hundreds of examples ofreal or mocked-up graphs, figures, and tables are used throughout the book; many have footnotes indicating possible variations, modifications, strengths, and weaknesses of the format shown. The chapters are well written and are constructed in a workbook style so that the reader can immediately apply it to his/her own data.
In short, the communication skills of the reader will be greatly enhanced by this book. Correction: seizure activity associated with antipsychotic therapy TO THE EDITOR: The article entitled "Seizure Activity Associated with Antipsychotic Therapy" (DICP 1990; 24:601-6) contains an error in the dose-equivalent ratio of clozapine to chlorpromazine (page 605). Clozapine therapy is equivalent to chlorpromazine therapy at a 1:2 ratio rather than a 2: I ratio as stated in the article; therefore, clozapine 250-1200 mg/d is equipotent to chlorpromazine 500-2400 rng/d. Please alert your readers to this incorrect information, and accept my apology for this mistake. 
Drug-Test Interactions
Handbook is an excellent compilation of information from many different textbooks and specialty journals. The listing of laboratory tests is not comprehensive, with rarely performed tests not covered. However, the most commonly performed tests are included.
The book is divided into three sections related to type of specimen required for testing (blood, urine, and miscellaneous). These sections are color-coded for easy use. Each section is divided into subsections of test groups and matrices. Test groups included are: (I) bone and joint diseases, (2) cardiovascular diseases, (3) glucose and diabetes, (4) hormones, (5) kidney function tests, (6) liver function tests, (7) therapeutic drug monitoring, and (8) thyroid function tests. Matrix A lists drug interactions according to test of interest and Matrix B lists interactions according to drug involved.
Each result reported in the matrix is followed by a summary that categorizes results into one of seven categories: (I) increase due to biologic effect, (2) decrease due to biologic effect, (3) no biologic effect, (4) increase due to analytical interference, (5) decrease due to analytical interference, (6) no analytical interference, and (7) unclassified.
The results summary is followed by the entry section which provides the method of analysis, dosage used, duration of dosage, number of subjects, description of subjects, summary of effect, and a reference number to the abstract from which the information was taken. An example is included.
Information is given related to frequency and degree of abnormality; however, many of the results are reported from single patients rather than from controlled studies and do not substantiate true abnormalities that occur consistently.
Drug-Test Interactions Handbook is a useful, ready reference for the libraries of pharmacotherapists, physicians, pathologists, clinical chemists, clinical laboratory scientists, and other allied health personnel. The material is useful, presented in a clear and well-organized manner, is not needlessly duplicated, and is up to date. The book's contents are very unique and should be in demand in the scientificl medical community. I would highly recommend this reference book to the readers of The Annals. 
